Analysis populations
The safety population included all randomized patients who received one dose or a partial dose of the investigational drugs. The PK population was a sub-set of the safety population with at least one evaluable PK blood sample for either artefenomel or ferroquine. The microbiological intention-to-treat population (mITT) included all randomized patients who received the investigational drugs, had microscopically confirmed 